New psoriasis pill tested for clearer skin
Disease control
Terminated
This study tested a daily pill called IRX4204 to see if it could safely improve skin symptoms in adults with mild to moderate plaque psoriasis. For 28 days, participants took either the drug or a placebo (inactive pill), and researchers compared their skin clearance and quality o…
Phase: PHASE2 • Sponsor: Io Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC